MDA-9 and uses thereof

Details MDA-9 and uses thereof MDA-9 and uses thereof

2005-03-15

2005-03-15

Canella, Karen A. (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S006120, C435S007100

Reexamination Certificate

active

06866993

ABSTRACT:
Increased expression of MDA-9 is associated with drug resistance of certain cells (e.g., cancer cells). The invention provides methods for identifying drug resistant cells by measuring the expression or activity of MDA-9, methods for identifying modulators of drug resistance, and methods for modulating drug resistance by modulating the expression or activity of MDA-9.

REFERENCES:
patent: 6071696 (2000-06-01), Fisher
patent: WO 9849290 (1998-11-01), None
Abstract of Stromskaya et al (Experimental and Toxicologic Pathology, 1995, vol. 47, pp. 157-166).*
Smith et al (The Journal of Biological Chemistry, 1995, vol. 270, pp. 28145-28152).*
Abstract of Zamboni et al (Clinical Cancer Research, 1998, vol. 4, pp. 743-753).*
Abstract of Zhou et al (Drugs, 1992, vol. 44, suppl. 4, pp. 1-16).*
Sadasivan et al, Cancer Letters, 1991, vol. 57, pp. 165-171.*
Berger et al, Journal of Medicinal Chemcistry, 1999, vol. 42, pp. 2145-2161.*
A. Branch, “A hitchhiker's guide to antisense and nonantisense biochemical pathways”, Hepatology, vol. 24, pp. 1517-1529, 1996.*
Broaddus et al, “Strategies for the design and delivery of antisense oligonucleotides in central nervous system”, Methods in Enzymology, vol. 314, pp. 121-135, 2000.*
Bertram et al, “Elevated expression of S100P, CAPL and MAGE3 in doxorubicin-resistant cell lines”, Anti-Cancer Drugs, vol. 9, pp. 311-317, Apr. 1998.*
Grootjans et al., “Syntenin, a PDZ protein that binds syndecan cytoplasmic domains” Proc. Nat'l. Acad. Sci. USA 94(25):13683-13688, 1997.
Harris et al., “Mechanisms of multidrug resistance in cancer treatment” Acta Oncologica 31(2):205-213, 1992.
Lin et al., “Characterization of a novel melanoma differentiation-associated gene, mda-9, that is . . . ” Mol. And Cell. Differentiation 4(4):317-333, 1996.
Scotto et al., “Amplification and expression of genes associated with multidrug resistance in mammalian cells” Science 232:751-755, 1986.
Simon et al., “Cell biological mechanisms of multidrug resistance in tumors” Proc. Nat'l. Acad. Sci. USA 91:3497-3504, 1994.
Waxman, J., “A new understanding of the hormonal regulation of endocrine dependant cancer” British Medical Bulletin 47(1):197-208, 1991.
GenBank Accession No. AF000652, Grootjans et al., Jan. 20, 1998.
GenBank Accession No. U83463, Burbelo, Apr. 2, 1997.
GenBank Accession No. AF006636, Lin et al., Mar. 18, 1998.

Affiliated with

Also associated with

Rating

MDA-9 and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with MDA-9 and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MDA-9 and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3450212